JP2025506472A5 - - Google Patents
Info
- Publication number
- JP2025506472A5 JP2025506472A5 JP2024547294A JP2024547294A JP2025506472A5 JP 2025506472 A5 JP2025506472 A5 JP 2025506472A5 JP 2024547294 A JP2024547294 A JP 2024547294A JP 2024547294 A JP2024547294 A JP 2024547294A JP 2025506472 A5 JP2025506472 A5 JP 2025506472A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- composition according
- vaccine composition
- liposome
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22156006.3 | 2022-02-09 | ||
| EP22156007 | 2022-02-09 | ||
| EP22156007.1 | 2022-02-09 | ||
| EP22156006 | 2022-02-09 | ||
| PCT/EP2023/053259 WO2023152260A1 (en) | 2022-02-09 | 2023-02-09 | Anti-alpha-synuclein therapeutic vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506472A JP2025506472A (ja) | 2025-03-11 |
| JP2025506472A5 true JP2025506472A5 (enExample) | 2026-02-13 |
Family
ID=85175955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547294A Pending JP2025506472A (ja) | 2022-02-09 | 2023-02-09 | 抗アルファシヌクレイン治療的ワクチン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250152684A1 (enExample) |
| EP (1) | EP4475878A1 (enExample) |
| JP (1) | JP2025506472A (enExample) |
| KR (1) | KR20240147981A (enExample) |
| AU (1) | AU2023219059A1 (enExample) |
| CA (1) | CA3248093A1 (enExample) |
| CL (1) | CL2024002370A1 (enExample) |
| CR (1) | CR20240371A (enExample) |
| IL (1) | IL314865A (enExample) |
| MX (1) | MX2024009485A (enExample) |
| WO (1) | WO2023152260A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024211543A1 (en) * | 2023-01-26 | 2025-07-17 | Ac Immune Sa | Liposomal construct |
| WO2025109524A1 (en) | 2023-11-22 | 2025-05-30 | Ac Immune Sa | Assays and methods for assessing vaccine preparations |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050203010A1 (en) | 2003-11-14 | 2005-09-15 | Atgen Co., Ltd. | Novel peptides conferring environmental stress resistance and fusion proteins including said peptides |
| AT506535B1 (de) | 2008-02-22 | 2010-04-15 | Affiris Forschungs & Entwicklungs Gmbh | Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden |
| AT508638B1 (de) | 2009-08-21 | 2011-08-15 | Affiris Ag | Verwendung von peptiden und polypeptiden zur behandlung und/oder prävention von synukleinopathien |
| EP2659907A1 (en) * | 2012-05-01 | 2013-11-06 | Affiris AG | Compositions |
| US12156912B2 (en) * | 2012-05-18 | 2024-12-03 | Board Of Regents Of The University Of Nebraska | Methods and compositions for inhibiting diseases of the central nervous system |
| RU2734924C2 (ru) | 2015-11-03 | 2020-10-26 | Аффирис Аг | Способ вакцинации против аутоантигена у пациента-человека |
| CN111787942B (zh) * | 2017-10-25 | 2024-03-29 | 杨森制药公司 | 磷酸化Tau肽的组合物及其用途 |
| AU2019253193B2 (en) * | 2018-04-10 | 2026-02-05 | Ac Immune Sa | Anti-abeta therapeutic vaccines |
| CA3185563A1 (en) * | 2020-08-04 | 2022-02-10 | Dorian WINTER | Immunogenic compounds |
-
2023
- 2023-02-09 KR KR1020247025028A patent/KR20240147981A/ko active Pending
- 2023-02-09 MX MX2024009485A patent/MX2024009485A/es unknown
- 2023-02-09 JP JP2024547294A patent/JP2025506472A/ja active Pending
- 2023-02-09 CA CA3248093A patent/CA3248093A1/en active Pending
- 2023-02-09 US US18/836,298 patent/US20250152684A1/en active Pending
- 2023-02-09 WO PCT/EP2023/053259 patent/WO2023152260A1/en not_active Ceased
- 2023-02-09 AU AU2023219059A patent/AU2023219059A1/en active Pending
- 2023-02-09 CR CR20240371A patent/CR20240371A/es unknown
- 2023-02-09 IL IL314865A patent/IL314865A/en unknown
- 2023-02-09 EP EP23703593.6A patent/EP4475878A1/en active Pending
-
2024
- 2024-08-07 CL CL2024002370A patent/CL2024002370A1/es unknown